Oncobit
Oncobit enabling personalized cancer care by developing precise and highly sensitive diagnostic and monitoring tests.
Oncobit has raised €4.1M across 2 funding rounds from 4 investors, most recently a round in Dec 2025. Based in Zurich, Switzerland; active in Healthtech. Data as of 28 Oct 2026.
Zurich, Switzerlandoncobit.com ↗
Total raised
€4.1M
€4,125,550
Funding rounds
2
Investors
4
distinct backers
Active since
2021-04
latest 2025-12
Funding by year
EUR raised per yearOncobit — funding by year — interactive chart.
Data table
| Oncobit — funding by year | |
|---|---|
| 2021 | €2.1M |
| 2025 | €2.0M |
Signals
High confidenceRaise-next likelihood38
base rate 30% for Other
- ▲ In typical raise window
- ▼ Low backer re-investment
Exit likelihood13
base rate 11% (2+ rounds)
- ▲ 5y since founding (typical exit age)
- ▲ Recently backed by strong-exit-track investors
Timing: in window vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-12-04 | Other | €2.0M | Existing investors,new investors | View deal → |
| 2021-04-30 | Seed | €2.1M | AVANTECA Partners,GF Group Holding | View deal → |
Investors
4Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData